Clinical Trials on Pulmonary Fibrosis Secondary to Systemic Sclerosis
Total 500 results
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisBelgium
-
Shanghai Jiao Tong University School of MedicineNot yet recruitingPeritoneal SclerosisChina
-
Chiesi Farmaceutici S.p.A.CompletedPartial Obstruction of Systemic to Pulmonary Artery Shunt | Complete Obstruction of Systemic to Pulmonary Artery ShuntUnited States
-
Assistance Publique - Hôpitaux de ParisHôpital Claude-HuriezCompletedSystemic Sclerosis | Interstitial Lung Disease | Scleroderma | Lung FibrosisFrance
-
Daval International LimitedUnknownSecondary Progressive Multiple SclerosisUnited Kingdom
-
Chang Gung Memorial HospitalCompletedSecondary Hyperparathyroidism Due to Renal CausesTaiwan
-
Fundación SenefroAbbVie; Effice Servicios Para la Investigacion S.L.CompletedSecondary Hyperparathyroidism Due to Renal CausesSpain
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Institute of Psychiatry and Neurology, WarsawPoznan University of Medical Sciences; Nalecz Institute of Biocybernetics and... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary ProgressivePoland
-
Tiziana Life Sciences LTDRecruitingSecondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis | Autoimmune Diseases of the Nervous System | Disease Progression | Secondary Progressive Multiple Sclerosis | Brain AtrophyUnited States, Canada
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Teva Pharmaceuticals USATerminatedRelapsing Remitting Multiple Sclerosis | Motor Deficits | Cognitive Deficits | Secondary-progressive Multiple SclerosisBelgium
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaboratorsUnknownPrimary Sclerosing Cholangitis | Primary Biliary Cholangitis | Secondary Sclerosing CholangitisNetherlands, Spain
-
Stanford UniversityPliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary Fibrosis | Primary Sclerosing Cholangitis | Covid19 PneumoniaUnited States
-
Hannover Medical SchoolGerman Research FoundationTerminatedSecondary Sclerosing CholangitisGermany
-
Medical University of GrazActive, not recruitingSecondary Sclerosing CholangitisAustria
-
ISDINDigna Biotech S.L.CompletedSkin FibrosisSpain, United Kingdom, Germany, Poland, Hungary, Italy
-
MediQuest TherapeuticsCompletedRaynaud Disease | Raynaud Disease Secondary to Scleroderma | Raynaud Secondary to Other Autoimmune DiseaseUnited States
-
MediQuest TherapeuticsUnknownRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Other Autoimmune DiseaseUnited States
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
Medical University of GrazRecruitingSecondary Sclerosis Cholangitis in Critically Ill PatientsAustria
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
Mack Biotech, Corp.Completed
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
University Hospital, GrenobleUnknownCystic Fibrosis Pulmonary ExacerbationFrance
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of TorontoTerminatedCystic Fibrosis Pulmonary ExacerbationCanada
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University of MilanCompletedChronic Obstructive Pulmonary Disease | Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients | Bronchodilator Agents | SalmeterolItaly
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Skane University HospitalKarolinska University HospitalCompletedSecondary Hyperparathyroidism | Disorder Related to Renal Transplantation
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Innobioscience SpAPontificia Universidad Catolica de Chile; University of Chile; Universidad Austral...UnknownMultiple Sclerosis, Secondary Progressive | Primary Progressive Multiple SclerosisChile
-
Novartis PharmaceuticalsCompletedSystemic Sclerosis, SclerodermaUnited States, Germany, Italy, Switzerland, United Kingdom
-
Immune Response BioPharma, Inc.croRecruitingMultiple Sclerosis | Secondary Progress Multiple SclerosisUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States